National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant fowlpox-prostate apecific antigen vaccine
A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:fowlpox-PSA vaccine
recombinant fowlpox-PSA vaccine
Abbreviation:rF-PSA



Previous:recombinant dHER2 vaccine, recombinant flt3 ligand, recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine, recombinant fowlpox-CEA(6D)/TRICOM vaccine
Next:recombinant fowlpox-TRICOM vaccine, recombinant fowlpox-tyrosinase vaccine, recombinant human 6Ckine, recombinant human chorionic gonadotropin, recombinant human EGF-rP64K/Montanide ISA 51 vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov